Unknown PHASE2 INTERVENTIONAL 2-arm NCT02016417

Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma

Phase II Study Comparing Gemcitabine Plus Cisplatin to Docetaxel, Cisplatin, and Fluorouracil Induction Chemotherapy Followed by Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

Sponsor: Cancer Hospital of Guangxi Medical University

Conditions Nasopharyngeal Carcinoma

Interventions A combination of Docetaxel, cisplatin and 5-Fluorouracil A combination of Gemcitabine and cisplatin

Updated 5 times since 2017 Last updated: Apr 15, 2014 Started: May 31, 2014 Primary completion: Dec 31, 2016 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Nasopharyngeal Carcinoma and is currently ongoing. Cancer Hospital of Guangxi Medical University leads this study, which shows 5 recorded versions since 2014 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2
Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cancer Hospital of Guangxi Medical University

Data source: Cancer Hospital of Guangxi Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.